New York (www.aktiencheck.de) - Moderna-Aktienanalyse von Wolfe Research:
1. Zusammenfassung der Bewertung
Wolfe Research bewertet die Aktie von Moderna Inc. (ISIN: US60770K1079,…
US stock market experienced a downward trend on Thursday, with both the Nasdaq Composite and the S&P 500 indices falling…
Shares of Moderna, Novavax, Pfizer, BioNTech and GSK closed lower on Thursday.…
…
Brad Miller, Modernas CIO, has driven technology innovation to help drive continued gains for the roughly $7 billion revenue pharmaceutical…
…
Toronto (www.aktiencheck.de) - Moderna-Aktienanalyse von RBC Capital Markets:
Aktuelle Bewertung
RBC Capital hat das Kursziel für Moderna Inc. (ISIN: US60770K1079, WKN: A2N9D9,…
Bloomberg Television brings you the latest news and analysis leading up to the final minutes and seconds before and after…
MRNA earnings call for the period ending September 30, 2024.…
…
These are the stocks posting the largest moves in premarket trading.…
…
CAMBRIDGE (dpa-AFX) - Der Covid-Impfstoffhersteller Moderna hat ein unerwartet gutes Quartal hinter sich. Der neueste Booster…
Warner Bros, Moderna, Under Armour and Lyft rise premarket…
Moderna shares surge after vaccine makers posts shallower-than-expected loss…
…
Moderna said its newest Covid vaccine saw benefits after winning approval in the U.S. three weeks earlier than the last…
Moderna reports surprise profit on higher-than-expected COVID vaccine sales…
Moderna CEO Bancel steps down as sales chief, Bloomberg Law reports…
Der Aktienkurs von Moderna befindet sich seit dem 1. August 2024 in einem Abwärtstrend. Bis in das Jahr 2026 sind…
Zürich (www.aktiencheck.de) - Moderna-Aktienanalyse von der UBS:
Aktuelle Bewertung
UBS hat das Kursziel für die Aktie von Moderna Inc. (ISIN: US60770K1079, WKN:…
New York (www.aktiencheck.de) - Moderna-Aktienanalyse von Sanford C. Bernstein & Co:
Aktuelle Bewertung
Das US-Analysehaus Bernstein hat die Berichterstattung über Moderna Inc.…
S. markets ended Thursday with mixed performance: the Dow Jones Industrial Average climbed 0.4% to 43,239.05.…
Shares of MRNA have been declining after it lowered its long-term financial guidance. It has also pushed its breakeven point…
GlaxoSmithKline sues Moderna for US patent infringement over COVID vaccines…
NEW YORK, Oct. 06, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…
NEW YORK, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…
NEW YORK, Oct. 02, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders…
…
NEW YORK, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…
Dr. Robert Langer, Co-Founder of Moderna, Joins Scientific Advisory Board of Klotho Neurosciences, Inc. (KLTO)…
Robbins LLP is Investigating Allegations that Metagenomi Inc. (MGX) Misled Investors Regarding its Relationship with Moderna, Inc.…
NEW YORK, Sept. 27, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…
NEW YORK, Sept. 22, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally…
NEW YORK, Sept. 21, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…
Theres no hope of it recovering to its prior heights anytime soon.…
Theres no hope of it recovering to its prior heights anytime soon.…
…
Robbins LLP is Investigating Allegations that Moderna, Inc. (MRNA) Misled Investors Regarding the Efficacy of its RSV Vaccine…
Die Moderna-Aktie stieg am Dienstag um über vier Prozent.…
Kulmbach (www.aktiencheck.de) - Moderna-Aktienanalyse von "Der Aktionär":
Marion Schlegel vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…
NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…
NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…
NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Moderna, Inc. ("Moderna"…
New York (www.aktiencheck.de) - Moderna-Aktienanalyse von Morgan Stanley:
Morgan Stanley senkt in einer aktuellen Aktienanalyse das Kursziel für die Aktie von…
…
…
…
NEW YORK, Sept. 14, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…
Moderna held its annual R&D day this week.…